• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析患者股三角区脓毒症:发生率、管理及结局

Femoral triangle sepsis in dialysis patients: frequency, management, and outcome.

作者信息

Morgan A P, Knight D C, Tilney N L, Lazarus J M

出版信息

Ann Surg. 1980 Apr;191(4):460-4. doi: 10.1097/00000658-198004000-00012.

DOI:10.1097/00000658-198004000-00012
PMID:7369811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1344568/
Abstract

Prosthetic devices for dialysis access sometimes have to be implanted in the groin. Infections are frequent there, and when they occur their management is influenced by the patients' need for continued dialysis, and often, by the presence of concomitant diseases. We report implantation of 161 dialysis access devices of various types, all utilizing the femoral vessels. Twenty-seven femoral triangle injections eventually occurred. Both the approach to their treatment and outcome were influenced by mode of presentation, localized infection being most favorable, and fever without localized signs least. The compromise surgical procedures made necessary by the patients' precarious medical status were successful in most instances but overall mortality was 18%, and the amputation rate 22%.

摘要

用于透析通路的假体装置有时必须植入腹股沟。那里感染很常见,感染发生时,其处理会受到患者持续透析需求的影响,而且往往还会受到伴发疾病的影响。我们报告了161例各种类型的透析通路装置植入情况,均利用股血管。最终发生了27例股三角感染。其治疗方法和结果均受感染表现方式的影响,局部感染最为有利,无局部体征的发热最不利。患者不稳定的医疗状况所必需的折衷手术程序在大多数情况下是成功的,但总体死亡率为18%,截肢率为22%。

相似文献

1
Femoral triangle sepsis in dialysis patients: frequency, management, and outcome.透析患者股三角区脓毒症:发生率、管理及结局
Ann Surg. 1980 Apr;191(4):460-4. doi: 10.1097/00000658-198004000-00012.
2
Good long term patency rates associated with an alternative technique in vascular access surgery--the adductor loop arteriovenous graft.采用一种替代技术进行血管通路手术——收肌袢动静脉移植物,可获得良好的长期通畅率。
Eur J Vasc Endovasc Surg. 2011 Apr;41(4):566-9. doi: 10.1016/j.ejvs.2010.09.019. Epub 2010 Oct 13.
3
Cryopreserved venous allograft is an acceptable conduit in patients with current or prior angioaccess graft infection.冷冻保存的静脉同种异体移植物对于当前或既往存在血管通路移植物感染的患者而言是一种可接受的管道。
J Vasc Surg. 2017 Oct;66(4):1157-1162. doi: 10.1016/j.jvs.2017.03.450. Epub 2017 Jun 21.
4
Surgical management of infected Thomas shunts.感染性托马斯分流术的外科治疗
Surgery. 1981 Mar;89(3):375-7.
5
The end stage of dialysis access: femoral graft or HeRO vascular access device.透析通路的终末期:股静脉移植物或HeRO血管通路装置。
Ann Vasc Surg. 2015 Jan;29(1):90-7. doi: 10.1016/j.avsg.2014.06.001. Epub 2014 Jun 18.
6
Dacron arterio-venous shunts for vascular access in hemodialysis.用于血液透析血管通路的涤纶动静脉分流管
Trans Am Soc Artif Intern Organs. 1973;19:33-7. doi: 10.1097/00002480-197301900-00006.
7
Management of the infected hemodialysis access grafts.感染性血液透析通路移植物的管理
Trans Am Soc Artif Intern Organs. 1983;29:360-2.
8
Vascular access in the lower limb.下肢血管通路
Eur J Vasc Endovasc Surg. 2009 Sep;38(3):373-4. doi: 10.1016/j.ejvs.2009.06.006. Epub 2009 Jul 4.
9
[Femoral arteriovenous bypass for hemodialysis using Thomas' prosthesis].[使用托马斯假体进行股动静脉旁路移植术用于血液透析]
Presse Med (1893). 1971 Oct 9;79(42):1865-6.
10
Reducing the risk of hemodialysis access.降低血液透析通路的风险。
Am J Kidney Dis. 1999 Aug;34(2):362-3. doi: 10.1016/s0272-6386(99)70370-7.

引用本文的文献

1
Genetic variation of aggrecanase-2 (ADAMTS5) in susceptibility to osteoarthritis.软骨聚集蛋白聚糖酶-2(ADAMTS5)的基因变异与骨关节炎易感性
Braz J Med Biol Res. 2019 Jan 10;52(2):e8109. doi: 10.1590/1414-431X20188109.
2
Long Term Outcomes of Arteriovenous Grafts for Hemodialysis in Lower Extremities.下肢动静脉内瘘用于血液透析的长期疗效
Vasc Specialist Int. 2016 Dec;32(4):180-185. doi: 10.5758/vsi.2016.32.4.180. Epub 2016 Dec 31.
3
Percutaneous transluminal angioplasty for dysfunctional femoral hemodialysis graft.经皮腔内血管成形术治疗功能不良的股部血液透析移植物
Diagn Interv Radiol. 2015 Mar-Apr;21(2):154-9. doi: 10.5152/dir.2014.14231.
4
Midterm experience of ipsilateral axillary-axillary arteriovenous loop graft as tertiary access for haemodialysis.同侧腋-腋动静脉袢状移植作为血液透析三级通路的中期经验
J Transplant. 2014;2014:908738. doi: 10.1155/2014/908738. Epub 2014 Mar 23.
5
Percutaneous intervention in axillary loop-configured arteriovenous grafts for chronic hemodialysis patients.经皮腔内介入治疗腋部袢状动静脉移植物在慢性血液透析患者中的应用。
Korean J Radiol. 2010 Mar-Apr;11(2):195-202. doi: 10.3348/kjr.2010.11.2.195. Epub 2010 Feb 22.
6
Vascular access surgery for hemodialysis.用于血液透析的血管通路手术。
Ann Surg. 1982 Dec;196(6):736-7.

本文引用的文献

1
Cause of death in acute renal failure.急性肾衰竭的死因
Arch Intern Med. 1962 Oct;110:493-504. doi: 10.1001/archinte.1962.03620220085014.
2
Management of sepsis complicating arterial reconstructive surgery.动脉重建手术并发脓毒症的管理。
Surgery. 1963 Jan;53:75-86.
3
Cannulation of blood vessels for prolonged hemodialysis.用于长期血液透析的血管插管
Trans Am Soc Artif Intern Organs. 1960;6:104-13.
4
Effects of infection and exposure on synthetic arterial prostheses.感染和暴露对人工合成动脉假体的影响。
AMA Arch Surg. 1959 Feb;78(2):271-9. doi: 10.1001/archsurg.1959.04320020093013.
5
Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula.采用静脉穿刺和外科造瘘进行慢性血液透析。
N Engl J Med. 1966 Nov 17;275(20):1089-92. doi: 10.1056/NEJM196611172752002.
6
A large-vessel applique A-V shunt for hemodialysis.一种用于血液透析的大血管贴附式动静脉分流器。
Trans Am Soc Artif Intern Organs. 1969;15:288-92.
7
Renal failure and infection.肾衰竭与感染。
Medicine (Baltimore). 1968 Jan;47(1):1-32. doi: 10.1097/00005792-196801000-00001.
8
Infection in arterial reconstruction with synthetic grafts.人工血管动脉重建术中的感染
Ann Surg. 1972 Sep;176(3):321-33. doi: 10.1097/00000658-197209000-00008.
9
Septicemia in patients on chronic hemodialysis.慢性血液透析患者的败血症
Ann Intern Med. 1978 Jan;88(1):28-33. doi: 10.7326/0003-4819-88-1-28.
10
Bacteremic infectability of vascular grafts: the influence of pseudointimal integrity and duration of graft function.血管移植物的菌血症感染性:假内膜完整性和移植物功能持续时间的影响。
Surgery. 1975 Aug;78(2):211-6.